Ledger.Open graph →
SEC Form D · filed September 25, 2018

Camp4 Therapeutics Corp

Offering
$34.1M
Sold
$34.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Shannon B. Stuckenberg · Tampa, FLDirectorMichelle Robson · Denver, CODirectorAriel L. Fainsod · Calgary, Alberta, CanadaDirectorNigel R. Cameron · Tampa, FLDirectorJohn P. Sumrall · Tampa, FLExec · DirectorMandeep Mundae · London, United KingdomDirectorJoseph L. Mcaleese · Cold Spring Harbor, NYDirectorRichard L. Baum, Jr · Cold Spring Harbor, NYExec · DirectorGordon L. Bonfield · Cold Spring Harbor, NYDirectorIsaac Barchas · West Lafayette, INDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗